These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19649907)

  • 1. Asymmetric processes in the large-scale preparation of chiral drug candidates.
    O'Brien MK; Vanasse B
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):793-806. PubMed ID: 19649907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and separation of optically active compounds. Part I.
    Gao Y; Boschetti E; Guerrier L
    Ann Pharm Fr; 1994; 52(4):184-203. PubMed ID: 7857027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis.
    Gawroński J
    Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral auxiliaries as emerging tools for the asymmetric synthesis of octahedral metal complexes.
    Meggers E
    Chemistry; 2010 Jan; 16(3):752-8. PubMed ID: 20013968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear effects in asymmetric catalysis.
    Satyanarayana T; Abraham S; Kagan HB
    Angew Chem Int Ed Engl; 2009; 48(3):456-94. PubMed ID: 19115268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
    Federsel HJ
    Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
    Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic asymmetric synthesis of chiral phosphanes.
    Glueck DS
    Chemistry; 2008; 14(24):7108-17. PubMed ID: 18491333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ FTIR reaction analysis of pharmaceutical-related chemistry and processes.
    Rein AJ; Donahue SM; Pavlosky MA
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):734-42. PubMed ID: 19649901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do single enantiomers have something special to offer?
    Caldwell J
    Hum Psychopharmacol; 2001 Dec; 16(S2):S67-S71. PubMed ID: 12404710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Racemates to Single Enantiomers - Chiral Synthetic Drugs over the last 20 Years.
    Murakami H
    Top Curr Chem; 2007; 269():273-99. PubMed ID: 23605355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct catalytic synthesis of enantiopure 5-substituted oxazolidinones from racemic terminal epoxides.
    Bartoli G; Bosco M; Carlone A; Locatelli M; Melchiorre P; Sambri L
    Org Lett; 2005 May; 7(10):1983-5. PubMed ID: 15876035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocatalysis for industrial production of fine chemicals.
    Schulze B; Wubbolts MG
    Curr Opin Biotechnol; 1999 Dec; 10(6):609-15. PubMed ID: 10600696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilibrium of homochiral oligomerization of a mixture of enantiomers. Its relevance to nonlinear effects in asymmetric catalysis.
    Tsukamoto M; Gopalaiah K; Kagan HB
    J Phys Chem B; 2008 Dec; 112(48):15361-8. PubMed ID: 19006277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.